15-Deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors
Publication type: Journal Article
Publication date: 2006-11-01
scimago Q1
wos Q1
SJR: 1.599
CiteScore: 9.4
Impact factor: 5.6
ISSN: 00062952, 18732968
PubMed ID:
16987499
Biochemistry
Pharmacology
Abstract
15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) has been known to display multifaceted cellular functions, including anti-inflammatory and cytoprotective effects. However, depending on the concentrations and intracellular microenvironment, this cyclopentenone prostaglandin can exert opposite effects. Because of the alpha,beta-unsaturated carbonyl moiety present in its cyclopentenone ring structure, 15d-PGJ(2) can act as a Michael reaction acceptor and readily interacts with critical cellular nucleophiles, such as cysteine thiol groups in proteins. Many of the biological effects induced by 15d-PGJ(2) involve redox-transcription factors as the potential targets. Thus, 15d-PGJ(2) can modulate the transcriptional activities of nuclear factor-kappaB (NF-kappaB), activator protein-1 (AP-1), nuclear factor-erythroid 2p45 (NF-E2)-related factors (Nrf2), hypoxia inducible factor (HIF), etc. 15d-PGJ(2) is also well known as an endogenous ligand of peroxisome proliferator-activated receptor gamma (PPARgamma). However, the regulation of the aforementioned redox-sensitive transcription factors by 15d-PGJ(2) is not necessarily mediated via PPARgamma activation, but rather involves covalent modification or oxidation of their critical cysteine residues acting as a redox-sensor. This commentary describes the biological and physiological functions of 15d-PGJ(2) and underlying biochemical and molecular mechanisms with emphasis on the modulation of redox-sensitive transcription factors and their regulators.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Free Radical Biology and Medicine
6 publications, 4.72%
|
|
|
Biochemical Pharmacology
6 publications, 4.72%
|
|
|
Endocrinology
4 publications, 3.15%
|
|
|
Antioxidants and Redox Signaling
4 publications, 3.15%
|
|
|
Biochemical and Biophysical Research Communications
4 publications, 3.15%
|
|
|
PPAR Research
4 publications, 3.15%
|
|
|
Cancer Research
4 publications, 3.15%
|
|
|
PLoS ONE
3 publications, 2.36%
|
|
|
Carcinogenesis
3 publications, 2.36%
|
|
|
Journal of Cancer Prevention
3 publications, 2.36%
|
|
|
Russian Journal of Organic Chemistry
2 publications, 1.57%
|
|
|
Acta Pharmacologica Sinica
2 publications, 1.57%
|
|
|
European Journal of Pharmacology
2 publications, 1.57%
|
|
|
Journal of Biological Chemistry
2 publications, 1.57%
|
|
|
Journal of Proteomics
2 publications, 1.57%
|
|
|
International Journal of Cardiology
2 publications, 1.57%
|
|
|
Free Radical Research
2 publications, 1.57%
|
|
|
Molecular Pharmacology
1 publication, 0.79%
|
|
|
Pharmacological Reviews
1 publication, 0.79%
|
|
|
American Journal of Respiratory and Critical Care Medicine
1 publication, 0.79%
|
|
|
Journal of Cell Science
1 publication, 0.79%
|
|
|
Lifestyle Genomics
1 publication, 0.79%
|
|
|
JOURNAL OF HEALTH SCIENCE
1 publication, 0.79%
|
|
|
Hepatology
1 publication, 0.79%
|
|
|
Experimental Biology and Medicine
1 publication, 0.79%
|
|
|
Cancers
1 publication, 0.79%
|
|
|
Cells
1 publication, 0.79%
|
|
|
International Journal of Molecular Sciences
1 publication, 0.79%
|
|
|
Frontiers in Immunology
1 publication, 0.79%
|
|
|
1
2
3
4
5
6
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Elsevier
44 publications, 34.65%
|
|
|
Wiley
10 publications, 7.87%
|
|
|
Springer Nature
7 publications, 5.51%
|
|
|
Hindawi Limited
6 publications, 4.72%
|
|
|
American Association for Cancer Research (AACR)
5 publications, 3.94%
|
|
|
Pleiades Publishing
4 publications, 3.15%
|
|
|
The Endocrine Society
4 publications, 3.15%
|
|
|
Mary Ann Liebert
4 publications, 3.15%
|
|
|
MDPI
4 publications, 3.15%
|
|
|
American Chemical Society (ACS)
4 publications, 3.15%
|
|
|
Taylor & Francis
4 publications, 3.15%
|
|
|
Oxford University Press
4 publications, 3.15%
|
|
|
Public Library of Science (PLoS)
3 publications, 2.36%
|
|
|
American Society for Biochemistry and Molecular Biology
3 publications, 2.36%
|
|
|
Korean Society of Cancer Prevention
3 publications, 2.36%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
2 publications, 1.57%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 1.57%
|
|
|
American Thoracic Society
1 publication, 0.79%
|
|
|
The Company of Biologists
1 publication, 0.79%
|
|
|
S. Karger AG
1 publication, 0.79%
|
|
|
Pharmaceutical Society of Japan
1 publication, 0.79%
|
|
|
SAGE
1 publication, 0.79%
|
|
|
Frontiers Media S.A.
1 publication, 0.79%
|
|
|
American Society for Microbiology
1 publication, 0.79%
|
|
|
The Society for Free Radical Research Japan
1 publication, 0.79%
|
|
|
Korean Association of Medical Journal Editors
1 publication, 0.79%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.79%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.79%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
127
Total citations:
127
Citations from 2025:
1
(0.79%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Kim E. et al. 15-Deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors // Biochemical Pharmacology. 2006. Vol. 72. No. 11. pp. 1516-1528.
GOST all authors (up to 50)
Copy
Kim E., SURH Y. 15-Deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors // Biochemical Pharmacology. 2006. Vol. 72. No. 11. pp. 1516-1528.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.bcp.2006.07.030
UR - https://doi.org/10.1016/j.bcp.2006.07.030
TI - 15-Deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors
T2 - Biochemical Pharmacology
AU - Kim, Eunhee
AU - SURH, Young-Joon
PY - 2006
DA - 2006/11/01
PB - Elsevier
SP - 1516-1528
IS - 11
VL - 72
PMID - 16987499
SN - 0006-2952
SN - 1873-2968
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2006_Kim,
author = {Eunhee Kim and Young-Joon SURH},
title = {15-Deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors},
journal = {Biochemical Pharmacology},
year = {2006},
volume = {72},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/j.bcp.2006.07.030},
number = {11},
pages = {1516--1528},
doi = {10.1016/j.bcp.2006.07.030}
}
Cite this
MLA
Copy
Kim, Eun-Hee, et al. “15-Deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.” Biochemical Pharmacology, vol. 72, no. 11, Nov. 2006, pp. 1516-1528. https://doi.org/10.1016/j.bcp.2006.07.030.